|
Volumn , Issue 3, 2008, Pages 62-66
|
Dysbiotic manifestations during eradication therapy of Helicobacter pylori and their corrections
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
PROBIOTIC AGENT;
ADULT;
AGED;
ARTICLE;
BIFIDOBACTERIUM;
BIOPSY;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DUODENUM ULCER;
DYSPEPSIA;
ENTEROPATHY;
FEMALE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
INTESTINE MUCOSA;
LACTOBACILLUS ACIDOPHILUS;
MALE;
MIDDLE AGED;
PATHOLOGY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SMALL INTESTINE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTI-INFECTIVE AGENTS;
ANTI-ULCER AGENTS;
BIFIDOBACTERIUM;
BIOPSY;
DRUG THERAPY, COMBINATION;
DUODENAL ULCER;
DYSPEPSIA;
FEMALE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
INTESTINAL DISEASES;
INTESTINAL MUCOSA;
INTESTINE, SMALL;
LACTOBACILLUS ACIDOPHILUS;
MALE;
MIDDLE AGED;
PROBIOTICS;
TREATMENT OUTCOME;
|
EID: 49649107214
PISSN: 03729311
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|